Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-002822-21Phase 4Completed
Phase 4, randomised trial of amoxicillin + clavulanate in influenza, influenza-like illness (ILI) and bacterial disease (2 arms), sponsored by University of Oxford. Primary endpoint: Clinical deterioration requiring re-consultation. Started Oct 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-002822-21.